Using Continuous Heart Monitoring to Diagnose and Manage Cardiac Patients with Dr. Waqaas Al-Siddiq Biotricity TRANSCRIPT
Download PDFMay 3, 2023
Dr. Waqaas Al-Siddiq, CEO and Founder of Biotricity, shines a light on the need for better data about heart rhythm throughout the day, not just for a limited time. Biotricity has developed a non-invasive, cost-effective, available over-the-counter monitor that provides patients and cardiologists with a new level of understanding of heart activity and enhances diagnosis and disease management.
Waqaas explains, "I'll take a step back to try to explain the problem that we were trying to solve. Dexcom created a continuous glucose monitor, saying that there are these data points that are in between when you're pricking your finger and collecting your information, which is quite valuable and insightful."
"In the continuous heart monitoring world, or in the heart world, patients don't really have anything. You have an implantable loop recorder, which records your ECG continuously. But you have to be a high-risk patient, it's a very high cost to get that implanted, and when it comes to a non-invasive solution, you have a 30-second ECG. If we look at the criteria, the patient issues are asymptomatic. They happen while you're sleeping. If it's a 30-second or 3-minute ECG and you're sleeping and don't feel the symptom, you're not waking up to collect that information. And even if you were, by the time you wake up and get the device, that information is gone."
#Biotricity #Cardiology #Cardiovascular #HeartDisease #Wearables #ContinuousHeartMonitoring
